Targeting GM-CSF in COVID-19 Pneumonia: Rationale and Strategies

COVID-19 is a clinical syndrome ranging from mild symptoms to severe pneumonia that often leads to respiratory failure, need for mechanical ventilation, and death. Most of the lung damage is driven by a surge in inflammatory cytokines [interleukin-6, interferon-γ, and granulocyte-monocyte stimulatin...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Front Immunol
Asıl Yazarlar: Bonaventura, Aldo, Vecchié, Alessandra, Wang, Tisha S., Lee, Elinor, Cremer, Paul C., Carey, Brenna, Rajendram, Prabalini, Hudock, Kristin M., Korbee, Leslie, Van Tassell, Benjamin W., Dagna, Lorenzo, Abbate, Antonio
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Frontiers Media S.A. 2020
Konular:
Immunology
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7348297/
https://ncbi.nlm.nih.gov/pubmed/32719685
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2020.01625
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller